These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10626807)

  • 1. Imaging brain tumors by targeting peptide radiopharmaceuticals through the blood-brain barrier.
    Kurihara A; Pardridge WM
    Cancer Res; 1999 Dec; 59(24):6159-63. PubMed ID: 10626807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retention of biologic activity of human epidermal growth factor following conjugation to a blood-brain barrier drug delivery vector via an extended poly(ethylene glycol) linker.
    Deguchi Y; Kurihara A; Pardridge WM
    Bioconjug Chem; 1999; 10(1):32-7. PubMed ID: 9893961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor radiopharmaceuticals: 111In chelation, conjugation to a blood-brain barrier delivery vector via a biotin-polyethylene linker, pharmacokinetics, and in vivo imaging of experimental brain tumors.
    Kurihara A; Deguchi Y; Pardridge WM
    Bioconjug Chem; 1999; 10(3):502-11. PubMed ID: 10346884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging endogenous gene expression in brain cancer in vivo with 111In-peptide nucleic acid antisense radiopharmaceuticals and brain drug-targeting technology.
    Suzuki T; Wu D; Schlachetzki F; Li JY; Boado RJ; Pardridge WM
    J Nucl Med; 2004 Oct; 45(10):1766-75. PubMed ID: 15471847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice.
    Panosa C; Fonge H; Ferrer-Batallé M; Menéndez JA; Massaguer A; De Llorens R; Reilly RM
    Nucl Med Biol; 2015 Dec; 42(12):931-8. PubMed ID: 26385534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates.
    Razumienko EJ; Chen JC; Cai Z; Chan C; Reilly RM
    J Nucl Med; 2016 Mar; 57(3):444-52. PubMed ID: 26429962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug targeting to the brain using avidin-biotin technology in the mouse; (blood-brain barrier, monoclonal antibody, transferrin receptor, Alzheimer's disease).
    Jeong Lee H; Pardridge WM
    J Drug Target; 2000; 8(6):413-24. PubMed ID: 11328667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of systemically administered radiolabeled epidermal growth factor as a brain tumor targeting agent.
    Yang W; Barth RF; Leveille R; Adams DM; Ciesielski M; Fenstermaker RA; Capala J
    J Neurooncol; 2001 Oct; 55(1):19-28. PubMed ID: 11804279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant forms of rat epidermal growth factor present in the urine of nude rats bearing human tumors.
    Hudgins WR; Orth DN; Stromberg K
    Cancer Res; 1988 Mar; 48(6):1428-34. PubMed ID: 3257897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular processing of (125)I- and (111)in-labeled epidermal growth factor (EGF) bound to cultured A431 tumor cells.
    Orlova A; Bruskin A; Sjöström A; Lundqvist H; Gedda L; Tolmachev V
    Nucl Med Biol; 2000 Nov; 27(8):827-35. PubMed ID: 11150717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor.
    Wu D; Yang J; Pardridge WM
    J Clin Invest; 1997 Oct; 100(7):1804-12. PubMed ID: 9312181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
    Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
    J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.
    Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C
    Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative biodistribution of potential anti-glioblastoma conjugates [111In]DTPA-hEGF and [111In]Bz-DTPA-hEGF in normal mice.
    Tolmachev V; Orlova A; Wei Q; Bruskin A; Carlsson J; Gedda L
    Cancer Biother Radiopharm; 2004 Aug; 19(4):491-501. PubMed ID: 15453964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [(111)In]Bz-DTPA-hEGF: Preparation and in vitro characterization of a potential anti-glioblastoma targeting agent.
    Sundberg AL; Orlova A; Bruskin A; Gedda L; Carlsson J; Blomquist E; Lundqvist H; Tolmachev V
    Cancer Biother Radiopharm; 2003 Aug; 18(4):643-54. PubMed ID: 14503960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
    Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
    J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of anti-epidermal growth factor receptor antibody on a human gastric cancer.
    Teramoto T; Onda M; Tokunaga A; Asano G
    Cancer; 1996 Apr; 77(8 Suppl):1639-45. PubMed ID: 8608556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiolabeling of epidermal growth factor with 99mTc and in vivo localization following intracerebral injection into normal and glioma-bearing rats.
    Capala J; Barth RF; Bailey MQ; Fenstermaker RA; Marek MJ; Rhodes BA
    Bioconjug Chem; 1997; 8(3):289-95. PubMed ID: 9177833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of functional epidermal growth factor receptors in a human hematopoietic cell line.
    Oval J; Hershberg R; Gansbacher B; Gilboa E; Schlessinger J; Taetle R
    Cancer Res; 1991 Jan; 51(1):150-6. PubMed ID: 1703031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.
    Xin H; Jiang X; Gu J; Sha X; Chen L; Law K; Chen Y; Wang X; Jiang Y; Fang X
    Biomaterials; 2011 Jun; 32(18):4293-305. PubMed ID: 21427009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.